Does Adjuvant Therapy Benefit Those with Small HER2-Positive Breast Cancers?

The trial examined HER2-positive breast cancer in patients with tumors smaller than 1cm; it is one of only a few to assess treatments in tumors this small.

Source: CancerNetwork - September 20, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news